Average Co-Inventor Count = 6.22
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Phio Pharmaceuticals Corp. (12 from 22 patents)
2. Rxi Pharmaceuticals Corporation (9 from 16 patents)
3. Biogazelle Nv (1 from 1 patent)
4. Rxi Parmaceuticals Corporation (1 from 1 patent)
22 patents:
1. 11584933 - RNA interference in ocular indications
2. 11279934 - Methods for treating cancer using nucleic acids targeting MDM2 or MYCN
3. 11118178 - Reduced size self-delivering RNAI compounds
4. 11021707 - Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA
5. 11001845 - Nucleic acid molecules targeting superoxide dismutase 1 (SOD1)
6. 10913948 - RNA interference in dermal and fibrotic indications
7. 10876119 - Reduced size self-delivering RNAI compounds
8. 10815485 - RNA interference in skin indications
9. 10774330 - Reduced size self-delivering RNAI compounds
10. 10662430 - RNA interference in ocular indications
11. 10240149 - Reduced size self-delivering RNAi compounds
12. 10184124 - RNA interference in ocular indications
13. 10041073 - Reduced size self-delivering RNAi compounds
14. 9963702 - RNA interference in dermal and fibrotic indications
15. 9938530 - RNA interference in skin indications